Michelle O’Shea

Endometriosis affects ∼5–14% of women/those presumed female at birth, with debilitating symptoms profoundly affecting workforce participation. This cross-sectional survey of 389 employed Australians with self-reported endometriosis examined…

Endometriosis and chronic pelvic pain (CPP) substantially affect work participation and productivity, yet workplace interventions remain largely unevaluated. This study piloted Endo@Work, a co-designed workplace guideline to support employe…

Background: Endometriosis costs Australia $9.7 billion AUD annually, with absenteeism and lost productivity mostly contributing to this cost burden. Previous research has shown how the absence of workplace support(s) for endometriosis sympt…

Endometriosis costs Australia $9.7 billion AUD annually, with most of the cost burden due to absenteeism and lost productivity. Previous research has shown how the absence of workplace support(s) for endometriosis symptom management exacerb…

Abstract Endometriosis affects 5–14% of women and those presumed female at birth (PFAB), yet public understanding remains limited. In an online survey of 427 Australians, diagnosed individuals had better knowledge about endometriosis than t…

Abstract Endometriosis symptoms, including persistent pelvic pain and fatigue, profoundly affect many people’s ability to undertake paid employment, globally the condition affects between 10-14% of women/those presumed female at birth. Des…

Abstract Endometriosis affects an estimated 6–14% of women and people presumed female at birth, significantly impacting quality of life and workplace productivity. While research highlights that endometriosis pain and symptom management hi…

(1) Objectives: This paper presents a scoping review of global evidence relating to interventions (i.e., policies, practices, guidelines, and legislation) aimed at supporting women to manage menstruation, menstrual disorders, and menopause …